Discount Agreement for Daridorexant (01.06.2026 - 31.05.2028)
DAK-Gesundheit is offering pharmaceutical companies the opportunity to enter into framework agreements for the active ingredient Daridorexant. This allows all interested firms to join at any time and under the same conditions.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
686 days remaining(LOT-0001)
Published